Search

Now showing items 1-2 of 2

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab

2022- Chaparro, M.; Bastón Rey, Iria; Fernández Salgado, Estela; González García, J.; Ramos, L.; [et al.]

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

2022- Chaparro, M.; Bastón Rey, Iria; Fernández Salgado, Estela; González García, J.; Ramos, L.; [et al.]